Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xintao Qiu

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|June 19, 2023
scATAnno: Automated Cell Type Annotation for single-cell ATAC Sequencing DataYijia Jiang, Zhirui Hu, Allen W Lynch, et al.
Genomics, Proteomics & Bioinformatics|November 24, 2025
scATAnno: Automated Cell Type Annotation for Single-cell ATAC Sequencing DataYijia Jiang, Zhirui Hu, Feng Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancerNicole A Traphagen, Esmé Wheeler, Rong Li, et al.
Cancer Discovery|April 3, 2025
Requirement for Cyclin D1 Underlies Cell Autonomous HIF2-Dependence in Kidney CancerNitin H Shirole, Devishi Kesar, Yenarae Lee, et al.
Molecular Cancer Therapeutics|September 7, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast CancerMaša Alečković, Zheqi Li, Ningxuan Zhou, et al.
Science (New York, N.Y.)|January 6, 2018
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killingDeng Pan, Aya Kobayashi, Peng Jiang, et al.
Research Square|September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerLeigh Ellis, Beatriz German, Katherine Morel, et al.
Nature Protocols|June 30, 2023
Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMALin Yang, Jin Wang, Jennifer Altreuter, et al.
Theranostics|June 5, 2026
Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironmentJoaquim Bellmunt, Yingtian Xie, Nuria Juanpere, et al.
Oncotarget|February 14, 2018
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|June 19, 2023
scATAnno: Automated Cell Type Annotation for single-cell ATAC Sequencing DataYijia Jiang, Zhirui Hu, Allen W Lynch, et al.
Genomics, Proteomics & Bioinformatics|November 24, 2025
scATAnno: Automated Cell Type Annotation for Single-cell ATAC Sequencing DataYijia Jiang, Zhirui Hu, Feng Lu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2026
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancerNicole A Traphagen, Esmé Wheeler, Rong Li, et al.
Cancer Discovery|April 3, 2025
Requirement for Cyclin D1 Underlies Cell Autonomous HIF2-Dependence in Kidney CancerNitin H Shirole, Devishi Kesar, Yenarae Lee, et al.
Molecular Cancer Therapeutics|September 7, 2023
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast CancerMaša Alečković, Zheqi Li, Ningxuan Zhou, et al.
Science (New York, N.Y.)|January 6, 2018
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killingDeng Pan, Aya Kobayashi, Peng Jiang, et al.
Research Square|September 2, 2025
EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate CancerLeigh Ellis, Beatriz German, Katherine Morel, et al.
Nature Protocols|June 30, 2023
Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMALin Yang, Jin Wang, Jennifer Altreuter, et al.
Theranostics|June 5, 2026
Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironmentJoaquim Bellmunt, Yingtian Xie, Nuria Juanpere, et al.
Oncotarget|February 14, 2018
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.
Pageof 7